The Chemours Company reports developments for a global industrial and specialty chemicals business organized around Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. News commonly covers earnings releases, quarterly dividends, debt financing, and segment demand for products sold under brands including Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™.
Company updates also address refrigerants and thermal-management applications, TiO2 pigment pricing and volume trends, advanced fluoropolymers for semiconductor and electronics markets, and collaborations tied to high-density IT cooling and other specialty-chemistry uses.
Chemours (NYSE: CC) launched Faizeon two-phase liquid cooling solutions for artificial intelligence, high-performance computing and high-density data centers. The portfolio covers direct-to-chip cooling and immersion cooling, using fluids that absorb heat as they change from liquid to vapor. In independent third-party testing, a direct-to-chip system using Faizeon 200 maintained a graphics processing unit at up to 19 degrees Celsius lower than a single-phase, water-based fluid while using a lower coolant flow rate.
Chemours says systems designed for the fluids can reduce cooling energy demand and nearly eliminate cooling-related water consumption, depending on system design and operating conditions. Its work to advance adoption includes engagements with Oak Ridge National Laboratory, NTT DATA, 2CRSi, DataVolt, Munters, Accelsius and ZutaCore.
Chemours (CC) reported third-quarter 2026 net income of $196 million, up from $46 million in the prior-year quarter. Diluted earnings rose to $1.29 from $0.31. Sales increased 3% to $1.540 billion, while adjusted EBITDA, a non-GAAP earnings measure, rose 6% to $200 million. Net income included $150 million of insurance proceeds recorded as a reduction in selling, general and administrative expense.
Titanium Technologies and Advanced Performance Materials grew, while Thermal & Specialized Solutions sales fell 9%. Free cash flow declined to $98 million from $105 million. Chemours completed its Kuan Yin property sale for approximately $340 million in total net consideration. Net debt was $3.2 billion at September 30. The company expects fourth-quarter sales to fall 5%–10% sequentially, with adjusted EBITDA of $160 million–$185 million; full-year adjusted EBITDA is expected at $775 million–$800 million.
Chemours (CC) declared a quarterly cash dividend of $0.0875 per common share for the fourth quarter of 2026.
The dividend will be paid on December 15, 2026, to stockholders of record as of the close of business on November 16, 2026.
Chemours (NYSE: CC) expects to release its third quarter 2026 financial results after market on November 2, 2026. The company also expects to hold a public conference call to discuss the results at 8:00 a.m. Eastern Standard Time on November 3, 2026. The live webcast, accompanying slides and webcast replay will be available at investors.chemours.com.
Summary not available.
Chemours (CC), together with DuPont and Corteva, has agreed to a $455 million settlement with North Carolina and 11 local entities to resolve PFAS-related litigations and other historical discharge claims tied to the Fayetteville Works facility and alleged PFAS contamination unrelated to that site.
The settlement will be paid over 15 years, beginning within 30 days of execution. Chemours will bear 50% of the payments under a 2021 MOU, with its share estimated at about $180 million on a net present value basis and around $50 million expected over the next 12 months. Of the total, $18 million relates to alleged PFAS contamination outside Fayetteville Works, including AFFF use. Existing accruals are expected to cover Chemours' share. The agreement also satisfies all future contributions to the MOU escrow, including a $50 million payment previously due in September 2026, and credits roughly $210 million of qualified spend under the MOU.
Chemours (NYSE: CC) released its 2025 Sustainability Report, detailing progress in responsible manufacturing, climate action, safety, and community engagement.
According to Chemours, the company has cut air and water process emissions of fluorinated organic chemicals by 80% since 2018, targeting a 99%+ reduction by 2030. Scope 1 and 2 greenhouse gas emissions are down 57%, approaching a 60% reduction goal by 2030, while absolute Scope 3 emissions have fallen 30%, aided by wider use of Opteon™ low-GWP refrigerants. In 2025, Chemours recorded zero Tier 1 process safety events and distribution safety incidents and launched its enterprise-wide “We Strive for Zero” safety aspiration. The report also highlights emissions detection and abatement technologies and cooling solutions that support AI infrastructure needs.
Chemours (NYSE: CC) announced the launch of Opteon™ ZE (R-1234ze(E)) and Opteon™ 515B (R-515B) refrigerants for stationary chiller applications serving AI-driven data centers, commercial buildings, and other mission-critical environments. The additions expand the low-global warming potential (GWP) Opteon™ portfolio targeting high-growth cooling markets.
Opteon™ ZE is an HFO refrigerant with an ultra-low GWP of approximately 1 (AR5), zero ozone depletion potential (ODP), ASHRAE A2L (mildly flammable) classification, and is suited for air- and water-cooled chillers, commercial AC, heat pumps, and data center cooling. Opteon™ 515B is a zero-ODP blend of about 91.1% R-1234ze(E) and 8.9% R-227ea, with GWP around 293 (AR4) and ASHRAE A1 (no flame propagation) classification, aimed at customers transitioning from higher-GWP refrigerants. Chemours highlights its fluorochemicals expertise, IP portfolio, and plans to provide dependable long-term supply. Both products are available now in strategic countries, with broader rollout expected based on demand.
Chemours (NYSE: CC) announced that its Board of Directors has declared a third-quarter 2026 quarterly cash dividend of $0.0875 per share on its common stock. The dividend is scheduled to be paid on September 15, 2026 to shareholders of record as of August 14, 2026.
The Chemours Company (NYSE: CC) reported Q2 2026 Net Sales of $1.59 billion, down 1% year-over-year, with a 4% volume decline partly offset by 2% higher pricing and a 1% currency benefit. Net loss attributable to Chemours narrowed to $274 million (‑$1.81 per diluted share) from a $380 million loss, reflecting legal and environmental reserves tied to settlements and ongoing litigation, partially offset by a gain on the Kuan Yin property sale.
Adjusted Net Income was $64 million ($0.42 per share) and Adjusted EBITDA was $247 million, down 5% year-over-year but up 46% sequentially. Free Cash Flow rose to $114 million, a 128% increase, with Free Cash Flow Conversion of 46% and net leverage reduced to 4.4x. TSS delivered $213 million Adjusted EBITDA (+3%), TT benefited from about 5% year‑to‑date TiO2 price increases, and APM’s Performance Solutions Net Sales grew 8% year-over-year. Chemours paid down €230 million of term loan debt and, for full-year 2026, continues to expect Net Sales growth of 1%–5% and Adjusted EBITDA of $775–$825 million, with Free Cash Flow Conversion above 25% and year-end net leverage around 3.8x.